Drug
18f Mfbg
18f Mfbg: highest development phase Phase 3, developed by Illumina. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Illumina
Trials
| Drug | Phase | Indication |
|---|---|---|
| 18F-MFBG NCT04724369 | Phase 3 | Neuroblastoma |
| 18F-MFBG NCT07176286 | Phase 2 | Parkinson Disease (PD) |
| 18F-mFBG NCT06233903 | Phase 2 | Neuroblastoma |
Latest
No recent events.
Follow 18f Mfbg on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.